为解决传统 BRCA1 检测方法的局限，伊朗研究人员开展纳米材料基生物传感器用于乳腺癌诊断的研究。结果显示这类传感器有高灵敏度等优势。推荐科研读者阅读，助力探索乳腺癌诊断新方向。 在全球范围内，乳腺癌就像一个 “健康杀手”，严重威胁着人们的生命健康。2020 年，全球大约有 230 万新的乳腺癌病例，68.5 万人因乳腺癌离世。而且，不同国家的乳腺癌发病率和死亡率差异很大，比如比利时每 10 ...

据《美国医学会杂志》发表的研究披露，研究人员开展的一项分析包括了近1万名BRCA1 或 BRCA2基因变异的妇女，这项分析旨在估测有这些基因突变的 ...

Pharmacogenomics. 2012;13(13):1523-1535. 5-year survival for stage III and IV (%): carriers, 38.1; noncarriers, 24.5 Median survival: p = 0.002 5-year survival for stage III and IV: p < 0.001 [46 ...

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a JAMA ...

BRCA基因又分为BRCA1和BRCA2，BRCA1和BRCA2都是具有抑制恶性肿瘤发生的基因。也就是说，如果BRCA1或BRCA2发生了基因突变，就意味着患乳腺癌的风险加大了。

The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

MRC Holland recently announced that five SALSA MLPA assays for the detection of hereditary breast and ovarian cancer (HBOC) ...

Around 50 out of 100 women with either a BRCA1 or BRCA2 gene mutations will get breast cancer by the time they are 70, while only to only 7 out of 100 women without the gene will develop cancer in ...